1. Home
  2. DNOW vs BHVN Comparison

DNOW vs BHVN Comparison

Compare DNOW & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

HOLD

Current Price

$12.59

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

BHVN

Biohaven Ltd.

HOLD

Current Price

$15.96

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNOW
BHVN
Founded
1862
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
DNOW
BHVN
Price
$12.59
$15.96
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
$16.67
$29.08
AVG Volume (30 Days)
3.2M
3.9M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
$2,648,000,000.00
N/A
Revenue This Year
$69.47
N/A
Revenue Next Year
$8.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.68
N/A
52 Week Low
$10.94
$7.48
52 Week High
$17.26
$18.57

Technical Indicators

Market Signals
Indicator
DNOW
BHVN
Relative Strength Index (RSI) 39.29 69.33
Support Level $11.35 $14.83
Resistance Level $13.91 $18.37
Average True Range (ATR) 0.44 1.01
MACD -0.12 0.15
Stochastic Oscillator 1.61 81.57

Price Performance

Historical Comparison
DNOW
BHVN

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: